Delivery Order SPE2DB25D3020-SPE2DB25FWHVX
Award Date
6/4/25
Potential Completion Date
6/5/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,204.62, is a Delivery Order for the supply of 4566816334 - Pitavastatin 1 mg Tablet, 90s. The contract has a firm fixed price pricing type and an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,413.35, is for the delivery of Pitavastatin 2 mg tablets. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Pitavastatin 2 mg tablets. The $1,996.37 firm fixed-price delivery order contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,182.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1002|SPE2DB25FLBJ7) for the supply of 4,568,038,848 units of the prescription medication Pitavastatin 1 mg tablet, with a performance period extending through April 28, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $1,206.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the delivery of 4,566,328,625 units of the prescription medication PITAVASTATIN 4 MG TABLET 90S. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.60 firm fixed-price contract is for the delivery of 4,567,157,688 tablets of the medication Pitavastatin 2 mg. The contract has a period of performance through February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pitavastatin 2 mg tablets. The contract has a ceiling value of $2,186.23 and a performance period through August 20, 2024. It is a firm fixed-price delivery order contract without a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award, valued at $1,829.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567039797 pitavastatin 2 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award, with the ID SPE2DX15D1053|SPE2DX24F6JYW, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $2,067.50 firm fixed price delivery order is for the supply of Pitavastatin 4 mg tablets. This order falls under Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite delivery contract (IDC) with DLA, which serves as...
This federal contract award, valued at $1,498.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4564513022 - PITAVASTATIN 2 MG TABLET 90S, a pharmaceutical product, with a completion date of May 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...